Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$406M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$351M |
| 3 |
Meta Platforms (Facebook)
META
|
+$316M |
| 4 |
Walmart
WMT
|
+$230M |
| 5 |
ServiceNow
NOW
|
+$217M |
Top Sells
| 1 |
Apple
AAPL
|
+$549M |
| 2 |
Palantir
PLTR
|
+$549M |
| 3 |
Netflix
NFLX
|
+$378M |
| 4 |
NVIDIA
NVDA
|
+$267M |
| 5 |
Alibaba
BABA
|
+$207M |
Sector Composition
| 1 | Technology | 17.41% |
| 2 | Healthcare | 14.96% |
| 3 | Consumer Discretionary | 11.86% |
| 4 | Financials | 11.03% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Precipio
PRPO
$34.3M
| $67.1K | ﹤0.01% |
10,700
+600
| +6% | +$3.76K |
|
3252
SOPHiA GENETICS
SOPH
$224M
| $66.7K | ﹤0.01% |
20,100
-800
| -4% | -$2.66K |
|
3253
P3 Health Partners
PIII
$28.4M
| $66.6K | ﹤0.01% |
8,117
+2,953
| +57% | +$24.2K |
|
3254
Carver Bancorp
CARV
$13.2M
| $65.6K | ﹤0.01% |
46,500
-7,100
| -13% | -$10K |
|
3255
Arena Group
AREN
$291M
| $65.4K | ﹤0.01% |
37,800
+13,100
| +53% | +$22.7K |
|
3256
Wah Fu Education Group
WAFU
$7.19M
| $65K | ﹤0.01% |
+40,600
| New | +$65K |
|
3257
Magnachip Semiconductor
MX
$110M
| $64.8K | ﹤0.01% |
18,900
-219,000
| -92% | -$751K |
|
|
AACG
3258
ATA Creativity
AACG
$67M
| $64.4K | ﹤0.01% |
64,444
-1,800
| -3% | -$1.8K |
|
3259
OmniAb
OABI
$226M
| $63.8K | ﹤0.01% |
+26,600
| New | +$63.8K |
|
3260
FAT Brands
FAT
$34.2M
| $63.6K | ﹤0.01% |
22,100
-19,341
| -47% | -$55.7K |
|
3261
PepGen
PEPG
$45.9M
| $63.6K | ﹤0.01% |
+45,300
| New | +$63.6K |
|
|
KNDI
3262
Kandi Technologies Group
KNDI
$113M
| $63.3K | ﹤0.01% |
44,600
-25,334
| -36% | -$36K |
|
3263
4D Molecular Therapeutics
FDMT
$324M
| $63.2K | ﹤0.01% |
+19,553
| New | +$63.2K |
|
|
CNTB
3264
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$98.1M
| $63.1K | ﹤0.01% |
114,800
-19,897
| -15% | -$10.9K |
|
3265
Athira Pharma
ATHA
$15M
| $62.4K | ﹤0.01% |
219,000
+11,700
| +6% | +$3.33K |
|
3266
Werewolf Therapeutics
HOWL
$64.5M
| $62.1K | ﹤0.01% |
63,900
+7,000
| +12% | +$6.81K |
|
3267
VistaGen Therapeutics
VTGN
$110M
| $62K | ﹤0.01% |
24,800
-58,900
| -70% | -$147K |
|
3268
PharmaCyte Biotech
PMCB
$6.86M
| $61.9K | ﹤0.01% |
49,500
+200
| +0.4% | +$250 |
|
3269
Anixa Biosciences
ANIX
$97.3M
| $61.4K | ﹤0.01% |
21,473
+6,900
| +47% | +$19.7K |
|
3270
Amtech Systems
ASYS
$116M
| $61.3K | ﹤0.01% |
12,700
+1,000
| +9% | +$4.83K |
|
|
SOHO
3271
Sotherly Hotels
SOHO
$16M
| $59.5K | ﹤0.01% |
80,514
-2,400
| -3% | -$1.78K |
|
3272
Marti Technologies
MRT
$190M
| $59.4K | ﹤0.01% |
19,088
-18,212
| -49% | -$56.6K |
|
3273
Oriental Culture Holding
OCG
$81.7M
| $57.3K | ﹤0.01% |
19,840
-200
| -1% | -$578 |
|
3274
HeartCore Enterprises
HTCR
$23.5M
| $57.3K | ﹤0.01% |
76,400
-25,400
| -25% | -$19.1K |
|
|
LGO
3275
Largo
LGO
$98.8M
| $57K | ﹤0.01% |
35,400
-18,000
| -34% | -$29K |
|